Acadia Healthcare Company Inc (NASDAQ:ACHC) currently has a daily average trading volume of 1.38M but it saw 5678242 shares traded in last market. With a market cap of 3.96B USD, the company’s current market price of $42.69 came falling about -18.03 while comparing to the previous closing price of $52.08. In past 52 weeks, the stock remained buoying in the range of price level as high as $87.77 and as low as $50.20. In the recent trading on the day, stock has struck highest price mark of $42.46 while lowest mark touched by it was $45.75.
Taking a look at 20-day trading activity of Acadia Healthcare Company Inc (ACHC) gives us an average price of $53.44, while its current price level is -51.36% below from 52-week high level whereas it is -14.96% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $66.37 while that of 200 days or SMA-200 reads an average of $71.80. A closer look into the stock’s movement over the week reveals that its volatility is standing at 3.93% during that period while stretching the period over a month that increases to 4.45%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 20.55 which implies that the stock is in oversold territory.
Deutsche Bank upgraded its recommendation for the stock as a “Hold” from “Sell” on April 25, 2024 while assigning a price target of $70. Barclays also issued its recommendations for the stock as it initiated the price target for the stock is $100.
Over the week, ACHC’s stock price is moving -16.65% down while it is -27.40% when we observe its performance for the past one month. Year-to-date it is -45.10% down and over the past year, the stock is showing a downside performance of -41.93%.
Currently, Acadia Healthcare Company Inc’s total number of outstanding shares is 91.26M. Company’s return on investment (ROI) stands at -0.11% and return on equity (ROE) at -0.17%. It has a 10.99 of forward P/E ratio. Stock’s beta reads 1.29. Stock has a price to book (P/B) ratio of 1.33 while price to sale or P/S ratio amounts to 1.30. Its return on asset (ROA) is -0.09% on average.
